
CEVR
@tuftscevr
Center for the Evaluation of Value & Risk in Health (CEVR) at @TuftsMedicalCtr. Postings and RTs are not endorsements.
ID: 563011611
https://cevr.tuftsmedicalcenter.org/ 25-04-2012 14:35:09
4,4K Tweet
2,2K Followers
2,2K Following

What does the future hold for the QALY - replacement or revision? Join CEVR for an online health policy seminar led by Chris Sampson, Sr. Principal Economist at Office of Health Economics, to find out. Oct. 2 from 2-3 pm ET. Details and join link here: cevr.tuftsmedicalcenter.org/events/cevr-he…

What is/will be the role of #CEA in public policy? Hear from Sarah Emond, Rena Conti, Lou Garrison, Steven Kymes, and Lisa Prosser PhD during Panel 4 at 10/26 Tufts-CEVR / Duke Margolis event. Register now: In-Person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…


Join us in Las Vegas for #AMCPNexus 2024 for 2 educational sessions by James Chambers and Molly Beinfeld's presentation of Fariel LaMountain's Platinum Ribbon-winning research on adalimumab product coverage. A full list of CEVR participation can be found here: cevr.tuftsmedicalcenter.org/news/spec-part…


We are pleased to announce that Brian Reid, a nationally-recognized expert in prescription drug policy and communications, has joined CEVR as a Senior Fellow. Brian's work w/ CEVR to focus on drug policy, IRA impacts, PBM effects on cost/access. More at: cevr.tuftsmedicalcenter.org/news/brian-rei…


What does the future hold for CEA? Hear from experts Davene R. Wright, PhD, Fernando Alarid-Escudero, @nlcrossnohere, and David Kim during Panel 5 at 10/26 Tufts-CEVR / Duke Margolis event. Register now: In-person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…





Drug value assessments are important, but economists shouldn't neglect assessment of health services and procedures. Hear perspectives from CEVR's Peter Neumann, Christopher Roebuck, and EBRI's Paul Fronstin during Oct. 31 public webinar. Register now: wellforce.zoom.us/webinar/regist…





What is the outlook for US payer coverage of specialty therapies in 2025? Expect more utilization management on pricey therapies. For more insights, register for CEVR's December 4 webinar led by James Chambers here: wellforce.zoom.us/webinar/regist…


The outlook for US payer coverage of specialty drugs in 2005. Register here for our webinar, Dec 4, 3-3:30 ET: tinyurl.com/2pndy8v8 James Chambers Molly Beinfeld NPC Brian Reid #heor #biosimilars CEVR


